These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recommendations to pharmacists for solving problems with large-volume parenterals. Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199 [No Abstract] [Full Text] [Related]
3. Continuous versus intermittent intravenous antibiotics. Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663 [No Abstract] [Full Text] [Related]
4. pH--an important factor in the compatibility of additives in intravenous therapy. Mary Edward Sister Am J Hosp Pharm; 1967 Aug; 24(8):440-9. PubMed ID: 6075729 [No Abstract] [Full Text] [Related]
5. Problems of intravenous additives. Ryan F RANF Rev; 1977 Jan; 8(1):1, 3. PubMed ID: 585112 [No Abstract] [Full Text] [Related]
6. The availability of antibiotics in combination with other additives in intravenous solutions. Dancey JW; Carew DP Am J Hosp Pharm; 1966 Oct; 23(10):543-51. PubMed ID: 5915776 [No Abstract] [Full Text] [Related]
7. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures. Zellmer WA Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972 [No Abstract] [Full Text] [Related]
8. Avoiding common perils of drug administration. Rosenthal K Nursing; 2007 Apr; 37(4):20-1. PubMed ID: 17413340 [No Abstract] [Full Text] [Related]
9. Stability papers and equal publishing opportunities. Klein CN Am J Hosp Pharm; 1991 Jul; 48(7):1454. PubMed ID: 1882872 [No Abstract] [Full Text] [Related]
10. Medication errors involving patient-controlled analgesia. Hicks RW; Heath WM; Sikirica V; Nelson W; Schein JR Jt Comm J Qual Patient Saf; 2008 Dec; 34(12):734-42. PubMed ID: 19119727 [No Abstract] [Full Text] [Related]
11. Prevention of medication error. Wang BC; Turndorf H N Y State J Med; 1981 Mar; 81(3):395-402. PubMed ID: 6938837 [No Abstract] [Full Text] [Related]
12. [Incompatibility of drugs designed for intravascular use]. Berglund A; Kolmodin CG; Hamfelt A; Lundgren A Lakartidningen; 1966 Jan; 63(4):296-7. PubMed ID: 5913320 [No Abstract] [Full Text] [Related]
13. Incompatibilities in large volume parenterals. Bergman HD Drug Intell Clin Pharm; 1977 Jun; 11(6):345-60. PubMed ID: 10297006 [No Abstract] [Full Text] [Related]
14. Mixing of additives in glass and plastic intravenous fluid containers. Bighley LD; Wille J; Lach JL Am J Hosp Pharm; 1974 Aug; 31(8):736-9. PubMed ID: 4853231 [No Abstract] [Full Text] [Related]
16. A pH pattern for I.V. additives. Webb JW Am J Hosp Pharm; 1969 Jan; 26(1):31-5. PubMed ID: 5763886 [No Abstract] [Full Text] [Related]
17. Medication errors associated with packaging and labeling of i.v. bags. Health Devices; 1997 Nov; 26(11):440-2. PubMed ID: 9360171 [No Abstract] [Full Text] [Related]
18. Considerations in using the i.v. route for drug delivery. Akers MJ Am J Hosp Pharm; 1987 Nov; 44(11):2528-30. PubMed ID: 3687992 [No Abstract] [Full Text] [Related]